Pharmaceutical Industry Blog

Last Updated: August 25, 2026 TL;DR: Oman is a high-maturity Gulf market with a regulator that is publishing its rulebook in the open. Medicines are handled by the Drug Safety Center of the Ministry of Health – the current body, replacing the older Directorate General naming that still circulates in secondary commentary – which registers first the company and then the product, entirely through the Ministry's e-portal, with a Technical Committee for Registration and Prices tak

Last Updated: August 25, 2026 TL;DR: Palestine is a market defined by two things a supplier has to plan around: a two-sided clearance requirement, and a public procurement channel that only a local partner can enter. Medicines are regulated by the General Directorate of Pharmacy and its Drug Registration Department within the Palestinian Ministry of Health, and the US International Trade Administration records that both Israeli and Palestinian Ministry of Health approvals and

Last Updated: August 24, 2026 TL;DR: The Central African Republic is a humanitarian-led market with almost no domestic manufacturing and a regulatory system still being rebuilt. Medicines are overseen by the Ministere de la Sante et de la Population through its pharmaceutical services directorate, which issues marketing authorisations, licenses pharmaceutical establishments and controls importation through authorised ports of entry, but publishes no fee schedule, review clock

Last Updated: August 24, 2026 TL;DR: Liberia is a small, donor-supported market with an unusually clear rulebook. The Liberia Medicines and Health Products Regulatory Authority (LMHRA), established under the LMHRA Act of 2010, requires every medicine sold in the country to be registered, accepts dossiers in WAHO Common Technical Document format, grants registrations valid for three years and commits to processing applications within three months of acknowledged receipt and pa

Last Updated: August 23, 2026 TL;DR: Lebanon imports roughly 70% of its medicines and registers every one of them at the Ministry of Public Health, where a Drug Registration Technical Committee reviews files built in CTD structure and a named Lebanese agent must appear in Module 1. Price is set as part of the marketing authorisation against a basket of seven European and seven Middle Eastern reference countries plus the country of origin, and imported generics are capped at u

Last Updated: August 23, 2026 TL;DR: Singapore is one of the most demanding pharmaceutical markets in Asia and one of the most rewarding to get right. The Health Sciences Authority (HSA) regulates therapeutic products under the Health Products Act 2007 and the Health Products (Therapeutic Products) Regulations 2016, was designated a WHO-Listed Authority for its medicines regulatory system on 26 October 2023, and had already attained WHO Maturity Level 4 in January 2022. For a